Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease

Summary

The objective of this study is to assess the safety and tolerability of YH14618 during 24 weeks of follow-up period after single administration in patients with degenerative disc disease.

Timeline

Start

2012-05

Primary completion

2014-01

Completion

2014-07

Drugs

Indications